OMNIPASS, created in 1997 (Belgium), from 2466 sister brands and 17477 competing brands. The OMNIPASS brand is owned by JOHNSON & JOHNSON, a company listed in New York. OMNIPASS belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
JOHNSON & JOHNSON
(OMNIPASS)
over 5 years*
USD 161.71